In our evaluated cohort of BRCA1/2 germline PV/LPV carriers, a greater proportion of cancer patients were female (95%) compared to non-cancer patients (64%), and cancer patients were older than non-cancer patients. The gene discussed is BRCA1; the disease is cancer.